Oncopeptides Total Shares Rise to 445,287,003 After Directed Issue

• Oncopeptides’ total issued shares reached 445,287,003 as of October 30, 2026.
• The total comprises 431,357,758 ordinary shares and 13,929,245 class C shares.
• Voting rights totaled 432,750,682.5; share capital stood at SEK 49.48 million.
• The change follows a directed issue of 50,000,000 ordinary shares to Swedish and international institutional investors, announced October 13, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oncopeptides AB published the original content used to generate this news brief on October 30, 2026, and is solely responsible for the information contained therein.